SCHEMBL835276

SCHEMBL835276

COc1ccc(O)c2c1CCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 3/20 0.49
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
MAOB P27338 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
JUN P05412 1/20 0.41
MME P08473 1/20 0.41
NFKB1 P19838 1/20 0.41
NOD2 Q9HC29 1/20 0.41
HSD11B1 P28845 2/20 0.41
HSD17B2 P37059 2/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HIF1A Q16665 1/20 0.41
EPAS1 Q99814 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6439147 0.96 ADRA1A (0.49) ADRA1ATHRATHRBMAOBMEN1
SCHEMBL833885 0.87 ADRA1A (0.59) ADRA1AHSD11B1HSD17B2ALDH1A1HPGD
SCHEMBL10969055 0.82 ADRA1A (0.59) ADRA1AHSD11B1HSD17B2ALDH1A1HPGD
SCHEMBL10802712 0.79 BCL2L1 (0.50) THRATHRBMAOBHSD11B1HSD17B2
SCHEMBL2722920 0.78 ADRA1A (0.52) ADRA1AMEN1KMT2ANFKB1ALDH1A1
SCHEMBL10835300 0.78 ALDH1A1 (0.59) MAOBMEN1KMT2AJUNMME
SCHEMBL6431712 0.78 KDM4E (0.59) MEN1KMT2AJUNMMENFKB1
SCHEMBL13274500 0.75 KDM4E (0.53) ADRA1AMEN1KMT2AALDH1A1HPGD
SCHEMBL15586581 0.75 ADRA1A (0.49) ADRA1AHSD11B1HSD17B2ALDH1A1HPGD
SCHEMBL31741626 0.75 ADRA1A (0.49) ADRA1AHSD11B1HSD17B2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2701673-B1 DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES L'ORÉAL (FR) 2017-09-13 EP disclosed
US-9241886-B2 Dye composition using a particular phenolic coupler in a medium rich in fatty substances, processes and devices L'OREAL (FR) 2016-01-26 US disclosed
US-9241886-B2 Dye composition using a particular phenolic coupler in a medium rich in fatty substances, processes and devices L'OREAL (FR) 2016-01-26 US disclosed
US-20140053346-A1 DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES L'OREAL (FR) 2014-02-27 US disclosed
US-20140053346-A1 DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES L'OREAL (FR) 2014-02-27 US disclosed
US-8378118-B2 Pyrazole-based thyroid receptor compounds TORRENT PHARMACEUTICALS LTD. (IN) 2013-02-19 US disclosed
US-8378118-B2 Pyrazole-based thyroid receptor compounds TORRENT PHARMACEUTICALS LTD. (IN) 2013-02-19 US disclosed
US-8378118-B2 Pyrazole-based thyroid receptor compounds TORRENT PHARMACEUTICALS LTD. (IN) 2013-02-19 US disclosed
US-20120202816-A1 NOVEL COMPOUNDS TORRENT PHARMACEUTICALS, LTD. (IN) 2012-08-09 US disclosed
US-20120202816-A1 NOVEL COMPOUNDS TORRENT PHARMACEUTICALS, LTD. (IN) 2012-08-09 US disclosed
EP-2061766-B1 NOVEL COMPOUNDS TORRENT PHARMACEUTICALS LTD (IN) 2010-08-18 EP disclosed
US-20100168110-A1 Novel Compounds TORRENT PHARMACEUTICALS LTD. (IN) 2010-07-01 US disclosed
US-20100168110-A1 Novel Compounds TORRENT PHARMACEUTICALS LTD. (IN) 2010-07-01 US disclosed
US-20100168110-A1 Novel Compounds TORRENT PHARMACEUTICALS LTD. (IN) 2010-07-01 US disclosed
EP-2061766-A2 NOVEL COMPOUNDS Torrent Pharmaceuticals Ltd (IN) 2009-05-27 EP disclosed
WO-2008149379-A2 NOVEL COMPOUNDS TORRENT PHARMACEUTICALS LTD. (IN) 2008-12-11 WO disclosed
US-20070173548-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands CHIANG YUAN-CHING P 2007-07-26 US disclosed
US-20070173548-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands CHIANG YUAN-CHING P 2007-07-26 US disclosed
US-7202275-B2 Malonamic acids and derivatives thereof as thyroid receptor ligands WARNER LAMBERT COMPANY LLC (US) 2007-04-10 US disclosed
US-7202275-B2 Malonamic acids and derivatives thereof as thyroid receptor ligands WARNER LAMBERT COMPANY LLC (US) 2007-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202816-A1 NOVEL COMPOUNDS TSHR, THRB, GPR119 ADRA1A 173/4885THRA 4/4885THRB 2/4885
US-20070173548-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands THRA, MC1R, TSHR ADRA1A 930/4885THRA 1/4885THRB 4/4885
US-20100168110-A1 Novel Compounds TSHR, THRB, GPR119 ADRA1A 173/4885THRA 4/4885THRB 2/4885
US-20140053346-A1 DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES C1R, F12, AKR1C3 ADRA1A 1032/4885THRA 3462/4885THRB 3099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.